Zamann Pharma Support logo

Siedlerstraße 7 | 68623 Lampertheim, Germany

info@zamann-pharma.com

Request an appointment now

Data Integrity: Key requirements for Computerized Systems

Data integrity ensures that data generated throughout the manufacturing process is accurate, reliable, and secure. Data integrity refers to the completeness, consistency, and accuracy of data throughout its lifecycle, from creation and processing to storage and retrieval.
  • Computerized System Validation, Data Integrity

A Four-Step Guide to Nitrosamine Risk Assessment and Mitigation

Discover the crucial steps pharmaceutical manufacturers must take to assess and mitigate nitrosamine risks in drug products. Learn how meticulous risk assessment, rigorous testing, and proactive strategies ensure product safety and global compliance. Read on to protect your patients and
  • Nitrosamine
Quality depar

What are Nitrosamines in the Pharmaceutical Industry ?

Dive deep into how nitrosamines, probable human carcinogens, can form during pharmaceutical manufacturing and the rigorous guidelines set by FDA and EMA to combat this risk. Discover the critical steps for risk assessment, testing, and mitigation that are ensuring drug
  • Nitrosamine
Nitrosamine impurities in Active Pharmaceutical Ingredients (API) and drug products

Essential Steps for Conducting Effective Periodic Reviews in CSV

Periodic reviews are conducted throughout the operational life of computerized system to verify that it remains in a validated state, complies with current regulatory requirements, is fit for intended use, and satisfies company policies and procedures. The review should confirm
  • Computerized System Validation, Periodic Review
Periodic Review of Computerized system

7 Steps to Conduct GAP Assessment for Computerized Systems

In Computer System Validation, GAP assessment serves to pinpoint differences between a company's existing procedures, practices, and policies and relevant regulatory guidelines and compliance standards. It involves gathering evidence to delineate the variance between requirements and current strengths.
  • Computerized System Validation, GAP Assessment

FDA 21 CFR Part 211 and Understanding its Requirements

21 CFR 211 compliance is your organization's stepping stone to meeting the FDA's definition of current good manufacturing practice (cGMP). Complying with 21 CFR 211 proves that your business has a safe, effective, consistent and quality-managed drug manufacturing operation in
  • Quality Management System

EU Annex 11 and its comparison with FDA 21 CFR Part 11

Unlock the secrets of regulatory compliance comparison of EU Annex11 and 21CFR Part 11! These guidelines differ in scope and requirements, ensuring your computerized systems meet the highest standards in pharmaceutical and life sciences.
  • Computerized System Validation, eQMS

IQ, OQ, PQ: Essential Steps for Equipment Qualification

Equipment quality in pharmaceutical manufacturing is ensured through IQ, OQ, and PQ phases, validating installation, performance, and user needs. Regulatory mandates prevent hazards, like mislabeling, with ongoing compliance via requalification. Expert guidance streamlines validation efforts for robust, compliant systems.
  • Equipment Qualification, Validation and Qualification

What is GAMP 5 Guideline? Checklist for GAMP 5 compliance

GAMP is the acronym used to summarize the term “Good Automated Manufacturing Practices“. These are a compilation of recommendations published by the International Society for Pharmaceutical Engineering (ISPE) in the form of a book to provide guidance on the compliance
  • Computerized System Validation, GAMP 5

Discover how to integrate AI Into Quality Management Workflows

The AI revolution brings unparalleled opportunities and challenges across all sectors, with life sciences and healthcare standing at the forefront due to their critical role in enhancing public health and quality of life. These areas hold immense potential for AI
  • eQMS, Quality Management System